Table I.
pT | pN | Grade | ||||
---|---|---|---|---|---|---|
Factors | ≤2 | ≥3 | 0 or X | ≥1 | ≤2 | 3 |
LVI (+), 5-FU (+) | 4 | 11 | 14 | 1 | 6 | 9 |
LVI (+), 5-FU (−) | 2 | 13 | 11 | 4 | 4 | 11 |
LVI (−), 5-FU (−) | 20 | 2 | 22 | 0 | 18 | 4 |
LVI, lymphovascular invasion; 5-FU, 5-fluorouracil.
pT | pN | Grade | ||||
---|---|---|---|---|---|---|
Factors | ≤2 | ≥3 | 0 or X | ≥1 | ≤2 | 3 |
LVI (+), 5-FU (+) | 4 | 11 | 14 | 1 | 6 | 9 |
LVI (+), 5-FU (−) | 2 | 13 | 11 | 4 | 4 | 11 |
LVI (−), 5-FU (−) | 20 | 2 | 22 | 0 | 18 | 4 |
LVI, lymphovascular invasion; 5-FU, 5-fluorouracil.